Search Results

There are 52599 results for: content related to: Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H

  1. Activation of extracellular signal-regulated kinase is critical for the discriminative stimulus effects induced by U-50,488H

    Synapse

    Volume 65, Issue 10, October 2011, Pages: 1052–1061, Kazumi Yoshizawa, Minoru Narita, Mai Saeki, Michiko Narita, Kana Isotani, Hiroshi Horiuchi, Satoshi Imai, Naoko Kuzumaki and Tsutomu Suzuki

    Article first published online : 26 APR 2011, DOI: 10.1002/syn.20937

  2. Role of dopamine D2 and D3 receptors in mediating the U-50,488H discriminative cue: comparison with methamphetamine and cocaine

    Addiction Biology

    Volume 17, Issue 6, November 2012, Pages: 949–955, Kazumi Yoshizawa, Minoru Narita, Tomohisa Mori, Mayumi Miyatake, Kana Isotani, Shiro Tomiyasu, Yoshi Tsukiyama and Tsutomu Suzuki

    Article first published online : 4 NOV 2010, DOI: 10.1111/j.1369-1600.2010.00257.x

  3. Inhibitory effects of SA4503 on the rewarding effects of abused drugs

    Addiction Biology

    Volume 19, Issue 3, May 2014, Pages: 362–369, Tomohisa Mori, Mahardian Rahmadi, Kazumi Yoshizawa, Toshimasa Itoh, Masahiro Shibasaki and Tsutomu Suzuki

    Article first published online : 31 AUG 2012, DOI: 10.1111/j.1369-1600.2012.00488.x

  4. REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade

    Addiction Biology

    Volume 12, Issue 3-4, September 2007, Pages: 227–462, Thomas M. Tzschentke

    Article first published online : 30 JUL 2007, DOI: 10.1111/j.1369-1600.2007.00070.x

  5. Comparison of the stimulus effects of ethylketocyclazocine in fischer and Sprague-Dawley rats

    Drug Development Research

    Volume 23, Issue 1, 1991, Pages: 65–73, Kenneth W. Locke, Barbara Gorney, Michael Cornfeldt and Stuart Fielding

    Article first published online : 5 OCT 2004, DOI: 10.1002/ddr.430230107

  6. Interaction between sufentanil and U-50488H with respect to antinociception and respiratory depression in rats

    Acta Anaesthesiologica Scandinavica

    Volume 41, Issue 7, August 1997, Pages: 895–902, C. M. L. VERBORGH, F. CAMU and T. F. MEERT

    Article first published online : 30 DEC 2008, DOI: 10.1111/j.1399-6576.1997.tb04806.x

  7. Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine

    Addiction Biology

    Tomohisa Mori, Toshimasa Itoh, Kazumi Yoshizawa, Yuya Ise, Keisuke Mizuo, Tomoya Saeki, Sachiko Komiya, Daiki Masukawa, Masahiro Shibasaki and Tsutomu Suzuki

    Article first published online : 27 JUL 2014, DOI: 10.1111/adb.12169

  8. Drug Discrimination and Mechanisms of Drug Action

    Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

    Richard A. Glennon, Richard Young, Pages: 183–216, 2011

    Published Online : 24 OCT 2011, DOI: 10.1002/9781118023150.ch6

  9. You have free access to this content
    The site of anti-arthritic action of the K-opioid, U-50,488H, in adjuvant arthritis: importance of local administration

    British Journal of Pharmacology

    Volume 118, Issue 7, August 1996, Pages: 1754–1760, Jodie L. Wilson, Vim Nayanar and Judith S. Walker

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15601.x

  10. You have full text access to this OnlineOpen article
    Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist

    British Journal of Pharmacology

    A M W Taylor, K W Roberts, A A Pradhan, H A Akbari, W Walwyn, K Lutfy, F I Carroll, C M Cahill and C J Evans

    Article first published online : 5 SEP 2014, DOI: 10.1111/bph.12810

  11. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A

    British Journal of Pharmacology

    B Simonson, A S Morani, A W M Ewald, L Walker, N Kumar, D Simpson, J H Miller, T E Prisinzano and B M Kivell

    Article first published online : 1 JUL 2014, DOI: 10.1111/bph.12692

  12. You have free access to this content
    Identification of benzomorphan-κ opiate receptors in cerebral arteries which subserve relaxation

    British Journal of Pharmacology

    Volume 82, Issue 2, June 1984, Pages: 459–466, Bella T. Altura, Burton M. Altura and Remi Quirion

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1984.tb10781.x

  13. Cardiovascular Actions of U50,488H and Related Kappa Agonists

    Cardiovascular Drug Reviews

    Volume 11, Issue 2, June 1993, Pages: 151–164, Michael K. Pugsley, William P. Penz and M. J. A. Walker

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1993.tb00273.x

  14. You have free access to this content
    Bremazocine: A κ-Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties

    CNS Drug Reviews

    Volume 11, Issue 2, March 2005, Pages: 195–212, Juanita Dortch-Carnes and David E. Potter

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2005.tb00270.x

  15. Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug Dependence

    Annals of the New York Academy of Sciences

    Volume 1025, Issue 1, October 2004, Pages: 404–413, KO HASEBE, KOJI KAWAI, TOMOHIKO SUZUKI, KUNIAKI KAWAMURA, TOSHIAKI TANAKA, MINORU NARITA, HIROSHI NAGASE and TSUTOMU SUZUKI

    Article first published online : 12 JAN 2006, DOI: 10.1196/annals.1316.050

  16. Discriminative Stimulus Properties of Receptor Antagonists

    Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

    Richard A. Glennon, Richard Young, Pages: 287–322, 2011

    Published Online : 24 OCT 2011, DOI: 10.1002/9781118023150.ch9

  17. Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection

    Hippocampus

    Volume 21, Issue 9, September 2011, Pages: 1010–1020, Eduard Schunk, Cornelia Aigner, Nadia Stefanova, Gregor Wenning, Herbert Herzog and Christoph Schwarzer

    Article first published online : 1 JUN 2010, DOI: 10.1002/hipo.20813

  18. Perceptual Drug Discriminative Aspects of the Endocannabinoid Signaling System in Animals And Man

    Drug Discrimination: Applications to Medicinal Chemistry and Drug Studies

    Richard A. Glennon, Richard Young, Pages: 241–285, 2011

    Published Online : 24 OCT 2011, DOI: 10.1002/9781118023150.ch8

  19. Evidence that the kappa agonist U50488H has non-opioid actions

    Journal of Pharmacy and Pharmacology

    Volume 40, Issue 10, October 1988, Pages: 718–720, A. G. HAYES, P. P. BIRCH and E. CAVICCHINI

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1988.tb07002.x

  20. You have free access to this content
    Cardiovascular actions of the κ-agonist, U-50,488H, in the absence and presence of opioid receptor blockade

    British Journal of Pharmacology

    Volume 105, Issue 3, March 1992, Pages: 521–526, M.K. Pugsley, W.P. Penz, M.J.A. Walker and T.M. Wong

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1992.tb09012.x